Annual Operating Expenses
$102.78 M
+$50.21 M+95.53%
December 31, 2023
Summary
- As of February 7, 2025, GPCR annual total operating expenses is $102.78 million, with the most recent change of +$50.21 million (+95.53%) on December 31, 2023.
- During the last 3 years, GPCR annual operating expenses has risen by +$86.87 million (+546.14%).
- GPCR annual operating expenses is now at all-time high.
Performance
GPCR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$45.84 M
+$12.52 M+37.58%
September 30, 2024
Summary
- As of February 7, 2025, GPCR quarterly total operating expenses is $45.84 million, with the most recent change of +$12.52 million (+37.58%) on September 30, 2024.
- Over the past year, GPCR quarterly operating expenses has increased by +$19.69 million (+75.31%).
- GPCR quarterly operating expenses is now at all-time high.
Performance
GPCR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
GPCR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +95.5% | +75.3% |
| 3 y3 years | +546.1% | +75.3% |
| 5 y5 years | +546.1% | +75.3% |
GPCR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +172.6% | at high | +261.1% |
| 5 y | 5-year | at high | +546.1% | at high | +261.1% |
| alltime | all time | at high | +546.1% | at high | +261.1% |
Structure Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $45.84 M(+37.6%) |
| Jun 2024 | - | $33.32 M(+4.1%) |
| Mar 2024 | - | $32.02 M(+3.3%) |
| Dec 2023 | $102.78 M(+95.5%) | $30.99 M(+18.5%) |
| Sep 2023 | - | $26.14 M(+0.6%) |
| Jun 2023 | - | $25.99 M(+32.3%) |
| Mar 2023 | - | $19.65 M(+51.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $52.56 M(+39.4%) | $12.96 M(+2.1%) |
| Sep 2022 | - | $12.69 M(-9.1%) |
| Jun 2022 | - | $13.96 M(+7.8%) |
| Mar 2022 | - | $12.95 M(-2.4%) |
| Dec 2021 | $37.70 M(+137.0%) | - |
| Dec 2021 | - | $13.27 M |
| Dec 2020 | $15.91 M | - |
FAQ
- What is Structure Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Structure Therapeutics?
- What is Structure Therapeutics annual operating expenses year-on-year change?
- What is Structure Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Structure Therapeutics?
- What is Structure Therapeutics quarterly operating expenses year-on-year change?
What is Structure Therapeutics annual total operating expenses?
The current annual operating expenses of GPCR is $102.78 M
What is the all time high annual operating expenses for Structure Therapeutics?
Structure Therapeutics all-time high annual total operating expenses is $102.78 M
What is Structure Therapeutics annual operating expenses year-on-year change?
Over the past year, GPCR annual total operating expenses has changed by +$50.21 M (+95.53%)
What is Structure Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of GPCR is $45.84 M
What is the all time high quarterly operating expenses for Structure Therapeutics?
Structure Therapeutics all-time high quarterly total operating expenses is $45.84 M
What is Structure Therapeutics quarterly operating expenses year-on-year change?
Over the past year, GPCR quarterly total operating expenses has changed by +$19.69 M (+75.31%)